American Industrial Partners (AIP) has entered into an agreement to acquire medical technology provider Avanos Medical in a definitive take-private transaction. This deal removes the Alpharetta, Georgia-based firm from public markets, valuing the entire company at roughly $1.272 billion. Stockholders of Avanos are set to receive $25.00 per share under the agreed-upon terms.

David Pacitti, currently serving as CEO, will continue to lead Avanos following the ownership change. Private equity transactions of this size often signal a strategic shift, allowing the new owner to implement long-term operational changes away from quarterly public scrutiny. Investors must now adjust their positions based on the impending privatization.

The acquisition is currently scheduled for completion during the second half of 2026, presenting a lengthy timeline for regulatory and closing procedures. This extended window suggests potential complexities or necessary governmental approvals tied to the transfer of ownership for the specialized medical equipment firm.

For shareholders, the $25.00 cash offer represents a clear exit price, finalizing the equity value proposition immediately upon closing. The transaction effectively monetizes the firm's assets under the direction of American Industrial Partners.